10 Prostate Cancer Clinical Trials in Madison, WI (2026)

Q: How do I join a clinical trial in Madison?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Madison research site will contact you.

Recruiting Prostate Cancer Studies in Madison

NCT06150417Recruiting

MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)

The purpose of this study is to find out if giving radiation therapy (RT) to areas of metastatic prostate cancer at the time a participant is diagnosed will help control disease better than the usual ...

Madison, WIPHASE2200 participantsCase Comprehensive Cancer Center

View Study Details

NCT06844383Recruiting

A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate

The purpose of this study is to find out whether talazoparib in combination with enzalutamide or talazoparib alone delays cancer progression in people with metastatic castration-resistant prostate can...

Madison, WIPHASE2126 participantsProstate Cancer Clinical Trials Consortium

View Study Details

NCT06141993Recruiting

ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials

This study will follow men with metastatic castration resistant prostate cancer throughout their standard of care treatment for their disease to determine if the presence of different genes or protein...

Madison, WI120 participantsDuke University

View Study Details

NCT06022822Recruiting

Placebo-Controlled Trial of Urolithin A Supplementation in Men With Prostate Cancer Undergoing Radical Prostatectomy, URO-PRO Trial

This phase II randomized control trial assesses the effect of Urolithin A (Uro-A) supplementation compared to placebo in men with biopsy-confirmed prostate cancer undergoing radical prostatectomy (RP)...

Madison, WIPHASE290 participantsNational Cancer Institute (NCI)

View Study Details

NCT06228053Recruiting

Study of SX-682 Plus Enzalutamide in Men With Abiraterone-Resistant Metastatic Castration Resistant Prostate Cancer

The goal of this clinical trial is to study the combination of SX-682 plus enzalutamide in men with metastatic castration resistant prostate cancer (mCRPC) who have failed abiraterone....

Madison, WIPHASE253 participantsSyntrix Biosystems, Inc.

View Study Details

NCT04489719Recruiting

Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer

This study investigates how well radium-223 works in treating patients with castration-resistant prostate cancer than has spread to the bones (bone metastases). Prostate cancer is the most common canc...

Madison, WI48 participantsUniversity of Washington

View Study Details

NCT06705686Recruiting

Novel ACK1 Inhibitor (R)-9b in Patients With Prostate Cancer

TITLE: Phase 1 First in Human Trial to Assess Safety and Tolerability of the Novel ACK1 Inhibitor (R)-9bMS in Patients with Prostate Cancer (PHAROS) STUDY DESCRIPTION: Prostate cancer (PC) patients r...

Madison, WIPHASE140 participantsTechnoGenesys, Inc.

View Study Details

NCT06675357Recruiting

Using FAPI PET/MRI to Evaluate Prostate Cancer

The goal of this clinical trial is to gain more information about how FAPI (fibroblast activation protein inhibitor) binds to certain type of cells in the tumor tissue. The main question it aims to an...

Madison, WIPHASE230 participantsUniversity of Wisconsin, Madison

View Study Details

NCT05647564Recruiting

PET/CT Characterization of Treatment Resistance

This study will use different types of medical imaging to assess how lesions from advanced prostate cancer become resistant to second-generation AR-targeted therapy, and how the different types of ima...

Madison, WINA25 participantsUniversity of Wisconsin, Madison

View Study Details

NCT07090148Recruiting

Trial of pTVG-HP+Nivo+Targeted Ablation of Resistant Lesions in Non-Castrate RecurrentOMPC

The goal of this clinical trial is to learn whether an experimental vaccine called pTVG-HP ("vaccine" or "DNA vaccine"), combined with a drug called nivolumab can increase the cancer-fighting ability ...

Madison, WIPHASE114 participantsUniversity of Wisconsin, Madison

View Study Details

About Prostate Cancer Clinical Trials in Madison

Prostate cancer develops in the prostate gland and is one of the most common cancers in men. Many prostate cancers grow slowly, but some can be aggressive. Treatment options range from active surveillance to surgery, radiation, and hormone therapy.

There are currently 10 prostate cancer clinical trials recruiting participants in Madison, WI. These studies are seeking a combined 746 participants. Research is being sponsored by Case Comprehensive Cancer Center, Prostate Cancer Clinical Trials Consortium, Duke University and 5 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Prostate Cancer Clinical Trials in Madison — FAQ

Are there prostate cancer clinical trials in Madison?

Yes, there are 10 prostate cancer clinical trials currently recruiting in Madison, WI. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Madison?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Madison research site will contact you about next steps.

Are clinical trials in Madison free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Madison studies also compensate for your time and travel.

What prostate cancer treatments are being tested?

The 10 active trials in Madison are testing new therapies including novel drugs, biologics, and treatment approaches for prostate cancer.

Data updated July 18, 2026 from ClinicalTrials.gov